COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines that was launched in 2020, will draw to a close on 31 December.
Jointly led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi), UNICEF and the World Health Organization (WHO), COVAX supplied nearly 2 billion COVID-19 vaccine doses and safe injection devices to 146 economies and helped to avert deaths of at least 2.7 million people. Guyana received a significant amount of vaccines through COVAX.
COVAX said 92 eligible lower-income economies will continue to have the option to receive COVID-19 vaccine doses and delivery support through Gavi’s regular programmes.
